Advantage Inpatient Med Spec Colorado Springs, CO - 80907

Advantage Inpatient Med Spec is categorized under Health Services in Colorado Springs, CO and active since 2011.

Advantage Inpatient Med Spec was established in 2011, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Duane R Spaulding at the company’s single location by writing to 2222 North Nevada Avenue, Colorado Springs, Colorado CO 80907 or by phoning (719) 776-5060. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Advantage Inpatient Med Spec
Contact Person: Duane R Spaulding
Address: 2222 North Nevada Avenue, Colorado Springs, Colorado 80907
Phone Number: (719) 776-5060
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 2011
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Health Services
SIC Code: 8099
NAICS Code: 6211110
Share This Business:

Advantage Inpatient Med Spec was started in 2011 to provide professional Health Services under the SIC code 8099 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Duane R Spaulding for inquiries that concern Advantage Inpatient Med Spec by calling the company number (719) 776-5060, as your correspondence is most welcome. Additionally, the physical location of the single location of Advantage Inpatient Med Spec can be found at the coordinates 38.865696,-104.819976 as well as the street address 2222 North Nevada Avenue in Colorado Springs, Colorado 80907.

For its online presence, you may visit Advantage Inpatient Med Spec’s website at and engage with its social media outlets through on Twitter and on Facebook.